{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:10:07Z","timestamp":1770815407258,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.anpede.2022.11.002","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T07:10:52Z","timestamp":1672643452000},"page":"58.e1-58.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations"],"prefix":"10.1016","volume":"98","author":[{"given":"Francisco Jos\u00e9","family":"\u00c1lvarez Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"\u00c1lvarez Alde\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Garc\u00e9s-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Garrote Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Iofr\u00edo de Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi\u00e1n","family":"Montesdeoca Meli\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Pineda Solas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Rivero Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepe","family":"Serrano Marchuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2022.11.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-056007","article-title":"Value of the Immunization Program Children in the 2017 US Birth Cohort","volume":"150","author":"Carrico","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpede.2022.11.002_bib0010","unstructured":"Centro Nacional de Epidemiolog\u00eda. CIBERESP. ISCIII. Informe epidemiol\u00f3gico sobre la situaci\u00f3n de la tos ferina en Espa\u00f1a, 2005\u20132020. Madrid, July 2022. [Accessed 30 September 2022]. Available from: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/TOSFERINA\/Informe_Tosferina_2005-2020_Julio.2022.pdf."},{"key":"10.1016\/j.anpede.2022.11.002_bib0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","article-title":"A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis","volume":"19","author":"Kandeil","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpede.2022.11.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.913922","article-title":"The impact of timing of pertussis vaccination during pregnancy on infant antibody levels at birth: a multi-country analysis","volume":"13","author":"Gomme","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.anpede.2022.11.002_bib0025","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.vaccine.2019.10.104","article-title":"Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large, randomized placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.anpede.2022.11.002_bib0030","unstructured":"Centro Nacional de Epidemiolog\u00eda, Instituto de Salud Carlos III. Vigilancia epidemiol\u00f3gica de la hepatitis B en Espa\u00f1a. Madrid; June 2022. Available from: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/Hepatitis%20B\/Vigilancia HepatitisB 2020.pdf."},{"key":"10.1016\/j.anpede.2022.11.002_bib0035","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2022.05.011","article-title":"Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study","volume":"40","author":"Savulescu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.anpede.2022.11.002_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-021-04386-0","article-title":"The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children","volume":"41","author":"Eichler","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.anpede.2022.11.002_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eimc.2020.02.016","article-title":"Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines","volume":"39","author":"Marimon","year":"2021","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"10.1016\/j.anpede.2022.11.002_bib0050","doi-asserted-by":"crossref","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide trends of invasive pneumococcal disease in Spain (2009\u20132019) in children and adults during the pneumococcal conjugate vaccine era","volume":"73","author":"de Miguel","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpede.2022.11.002_bib0055","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/hv.29511","article-title":"Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States","volume":"10","author":"Krishnarajah","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpede.2022.11.002_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.anpedi.2019.06.001","article-title":"Recomendaciones para la vacunaci\u00f3n frente a ROTAvirus de los reci\u00e9n nacidos PREMaturos (ROTAPREM)","volume":"91","author":"\u00c1lvarez-Alde\u00e1n","year":"2019","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpede.2022.11.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2021.0347","article-title":"Association of rotavirus vaccines with reduction in rotavirus gastroenteritis in children younger than 5 years: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"175","author":"Sun","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.anpede.2022.11.002_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Meningococcal group B vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpede.2022.11.002_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/vaccines8030469","article-title":"Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014\u20132018)","volume":"8","author":"Azzari","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.anpede.2022.11.002_bib0080","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/jama.2020.20449","article-title":"Association of use of a meningococcus group B vaccine with group B invasive meningococcal disease among children in Portugal","volume":"324","author":"Rodrigues","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.anpede.2022.11.002_bib0085","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","article-title":"Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpede.2022.11.002_bib0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.anpede.2022.11.002_bib0095","unstructured":"WHO: Vaccines against influenza. WHO position paper \u2014 November 2012. [Accessed 30 September 2022]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/241993."},{"key":"10.1016\/j.anpede.2022.11.002_bib0100","unstructured":"Centers for Disease Control and Prevention: 2019\u201320 season\u2019s pediatric flu deaths tie high mark set during 2017\u20132018 Season 2021. [Accessed 30 September 2022]. Available from: https:\/\/www.cdc.gov\/flu\/spotlights\/2019-2020\/2019-20-pediatric-flu-deaths.htm."},{"key":"10.1016\/j.anpede.2022.11.002_bib0105","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.vaccine.2021.12.011","article-title":"Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: an ecological study among London children, 2012\u20132018","volume":"40","author":"Lacy","year":"2022","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2022.11.002_bib0110","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1016\/j.vaccine.2019.05.056","article-title":"Duration of immunity to measles, rubella and mumps during the first year of life","volume":"37","author":"Cilleruelo","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.anpede.2022.11.002_bib0115","article-title":"Vaccines for measles, mumps, rubella, and varicella in children","volume":"4","author":"Di Pietrantonj","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpede.2022.11.002_bib0120","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2021.02.074","article-title":"Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants","volume":"39","author":"Habib","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.anpede.2022.11.002_bib0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.vaccine.2021.11.063","article-title":"Modelling varicella vaccination \u2014 what does a lack of surge in herpes zoster incidence tell us about exogenous boosting?","volume":"40","author":"Widgren","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.anpede.2022.11.002_bib0130","unstructured":"FDA news release. Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 vaccines for children down to 6 months of age. [Accessed 30 September 2022]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children."},{"key":"10.1016\/j.anpede.2022.11.002_bib0135","unstructured":"CDC. Advisory Committee on Immunization Practices. COVID-19 ACIP Vaccine recommendations. [Accessed 30 September 2022]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/vacc-specific\/covid-19.html."},{"key":"10.1016\/j.anpede.2022.11.002_bib0140","unstructured":"World Health Organization. Interim statement on COVID-19 vaccination for children. 11 August 2022 Statement. [Accessed 30 September 2022]. Available from: https:\/\/www.who.int\/news\/item\/11-08-2022-interim-statement-on-covid-19-vaccination-for-children."},{"key":"10.1016\/j.anpede.2022.11.002_bib0145","unstructured":"Ministerio de Sanidad. Gobierno de Espa\u00f1a. Estrategia de vacunaci\u00f3n COVID-19. [Accessed 30 September 2022]. Available from: https:\/\/www.vacunacovid.gob.es\/."},{"key":"10.1016\/j.anpede.2022.11.002_bib0150","article-title":"Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant","author":"Dorabawila","year":"2022","journal-title":"medRxiv [Internet]"},{"key":"10.1016\/j.anpede.2022.11.002_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(22)01185-0","article-title":"Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January\u2013April","volume":"202","author":"Sacco","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.anpede.2022.11.002_bib0160","doi-asserted-by":"crossref","unstructured":"Pich\u00e9-Renaud PP, Swayze S, Buchan S, Wilson SE, Austin PC, Morris SK, et al. Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators Group. Vaccine effectiveness of BNT162b2 against omicron in children aged 5\u201311 years: a test-negative design. Preprint The Lancet. 1 August 2022. [Accessed 30 September 2022]. Available from: https:\/\/ssrn.com\/abstract=4176388.","DOI":"10.2139\/ssrn.4176388"},{"key":"10.1016\/j.anpede.2022.11.002_bib0165","unstructured":"Su JR. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. COVID-19 vaccine safety updates. [Accessed 30 September 2022]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-01-05\/02-covid-su-508.pdf."},{"key":"10.1016\/j.anpede.2022.11.002_bib0170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mort Wkly Rep"},{"key":"10.1016\/j.anpede.2022.11.002_bib0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-20-0846","article-title":"Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15\u201329 years in the united states, 1999\u20132017: an ecologic study","volume":"30","author":"Mix","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.anpede.2022.11.002_bib0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jop.13091","article-title":"The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hospital-based population: a cross-sectional study of patient\u2019s registry","volume":"50","author":"Katz","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.anpede.2022.11.002_bib0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/vaccines8010117","article-title":"Trends of adverse events following immunization (AEFI) reports of human papillomavirus vaccine in the Valencian community\u2014Spain (2008\u20132018)","volume":"8","author":"Egoavil","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.anpede.2022.11.002_bib0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1185\/03007995.2015.1136606","article-title":"Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004\u20132012","volume":"32","author":"S\u00e1nchez-Luna","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anpede.2022.11.002_bib0195","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"MELODY Study Group. Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpede.2022.11.002_bib0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Nirsevimab study group single dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:45:56Z","timestamp":1762422356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287922002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2341287922002332"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2022.11.002","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}